NCT05373745

Brief Summary

The investigators aim to conduct a fully powered randomized controlled trial to compare the efficacy of two symptom management programs for older adults with early cognitive decline (either self-reported or confirmed by testing) and chronic pain, Active Brains 1 and Active Brains 2. The investigators will assess how each program may help in improving multimodal physical, cognitive and emotional function. The investigators will also assess whether improvements in outcomes from the two programs are maintained through 6-months follow-up. The investigators will also explore whether improvements in outcomes are mediated by nonadaptive pain reactions, adaptive coping, social factors and compensatory strategies and modified by demographic and clinical predictors. Both programs will be delivered virtually (Zoom).

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
260

participants targeted

Target at P75+ for not_applicable chronic-pain

Timeline
8mo left

Started Jun 2022

Longer than P75 for not_applicable chronic-pain

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress86%
Jun 2022Dec 2026

First Submitted

Initial submission to the registry

April 15, 2022

Completed
28 days until next milestone

First Posted

Study publicly available on registry

May 13, 2022

Completed
1 month until next milestone

Study Start

First participant enrolled

June 20, 2022

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Expected
Last Updated

February 23, 2026

Status Verified

February 1, 2026

Enrollment Period

3.5 years

First QC Date

April 15, 2022

Last Update Submit

February 20, 2026

Conditions

Keywords

Chronic PainMild Cognitive ImpairmentOlder AdultsPhysical ActivityMemory Related ProblemsEarly Cognitive Decline

Outcome Measures

Primary Outcomes (3)

  • Change in PROMIS Physical Function

    Change in rate of a participant's capability rather than performance of physical activities, with items ranging from 1-4. Higher T scores indicate greater physical function.

    0 Weeks, 8 Weeks, 6 Months

  • Change in Step Count via the ActiGraph wGT3X-BTLE Accelerometer

    Measures the change in steps during the 7 days preceding baseline assessment, throughout the intervention period, and 7 days preceding 6-month follow-up.

    0 Weeks, 8 Weeks, 6 Months

  • Change in six-minute walk test (6MWT)

    Assesses distance walked in 6 minutes.

    0 Weeks, 8 Weeks, 6 Months

Secondary Outcomes (5)

  • Repeatable Battery for the Assessment of Neuropsychological Status (RBANS)

    0 Weeks, 8 Weeks, 6 Months

  • Everyday Cognition Scale (eCog-12)

    0 Weeks, 8 Weeks, 6 Months

  • PROMIS Depression

    0 Weeks, 8 Weeks, 6 Months

  • PROMIS Anxiety

    0 Weeks, 8 Weeks, 6 Months

  • Numerical Rating Scale

    0 Weeks, 8 Weeks, 6 Months

Other Outcomes (15)

  • Change in PROMIS Pain Interference - Short Form 6b V1.0

    0 Weeks, 8 Weeks, 6 Months

  • Pain Catastrophizing Scale

    0 Weeks, 8 Weeks, 6 Months

  • Tampa Kinesiophobia Scale

    0 Weeks, 8 Weeks, 6 Months

  • +12 more other outcomes

Study Arms (2)

Active Brains 1

EXPERIMENTAL

Active Brains 1 uses a multimodal approach to introduce and reinforce new skills, including didactics, in-session activities, discussions and weekly practice assignments (homework). The Active Brains sessions teach skills and strategies to manage early cognitive concerns and chronic pain. The format is an 8-week program with weekly meetings and a focus on relaxation response strategies, cognitive behavioral training, positive psychology and mind-body interactions. Active Brains 1 uses a wrist-worn digital monitoring device (ActiGraph) for recording of physical activity.

Behavioral: Active Brains 1

Active Brains 2

PLACEBO COMPARATOR

This active comparison condition controls for the effect of time spent, group member support/feedback and interventionist support/feedback. Active Brains 2 addresses population-specific challenges of chronic pain and early cognitive decline symptoms. Participants also receive lifestyle education consistent from public health recommendations and standards for health promotion (e.g., "Sleep", "Nutrition", "Healthy Weight" and "Medical appointments". The Active Brains 2 program consists on 8 group sessions (each session is 90 minutes) that occur concurrently with the active intervention condition. The Active Brains 2 is conducted in the same format as Active Brains 1, but participants are not taught the mind-body, walking or cognitive-behavioral skills. Active Brains 2 uses a wrist-worn digital monitoring device (ActiGraph) for recording of physical activity.

Behavioral: Active Brains 2

Interventions

Active Brains 1BEHAVIORAL

Active Brains 1 uses a multimodal approach to introduce and reinforce new skills, including didactics, in-session activities, discussions and weekly practice assignments (homework). The Active Brains sessions teach skills and strategies to manage early cognitive concerns and chronic pain. The format is an 8-week program with weekly meetings and a focus on relaxation response strategies, cognitive behavioral training, positive psychology and mind-body interactions. Active Brains 1 uses a wrist-worn digital monitoring device (ActiGraph) for recording of physical activity.

Active Brains 1
Active Brains 2BEHAVIORAL

This active comparison condition controls for the effect of time spent, group member support/feedback and interventionist support/feedback. Active Brains 2 addresses population-specific challenges of chronic pain and early cognitive decline symptoms. Participants also receive lifestyle education consistent from public health recommendations and standards for health promotion (e.g., "Sleep", "Nutrition", "Healthy Weight" and "Medical appointments". The Active Brains 2 program consists on 8 group sessions (each session is 90 minutes) that occur concurrently with the active intervention condition. The Active Brains 2 is conducted in the same format as Active Brains 1, but participants are not taught the mind-body, walking or cognitive-behavioral skills. Active Brains 2 uses a wrist-worn digital monitoring device (ActiGraph) for recording of physical activity.

Active Brains 2

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male and female outpatients, age 60 years or older
  • Have nonmalignant chronic pain for more than 3 months
  • Reports early cognitive decline (subjective or objective)
  • Telephone Interview for Cognitive Status-30 score greater than or equal to 17
  • Functional Activities Questionnaire score less than 9
  • Able to perform a 6-minute walk test at an accelerated pace
  • English fluency/literacy
  • Willingness and ability to participate and use an ActiGraph watch and smartphone app to view and sync the step count and sleep data
  • Free of concurrent psychotropic or pain medication for at least 2 weeks prior to initiation of treatment, OR stable on current psychotropic or pain medication for a minimum of 6 weeks and willing to maintain a stable dose
  • Cleared by a medical doctor for study participation and no self-reported concerns about physical functioning on the revised Physical Activity Readiness Questionnaire (PAR-Q; score 0)

You may not qualify if:

  • Diagnosed with dementia or neurodegenerative disease
  • Diagnosed with medical illness expected to worsen in the next 6 months
  • Diagnosed with serious untreated mental illness (i.e., schizophrenia) or untreated substance use disorder
  • Current suicidal ideation reported on self-report
  • Engaging in regular mindfulness practice \> 45 min/week or has completed a course of cognitive behavioral therapy in the past 3 months
  • Regular use of a digital-monitoring device
  • Engagement in regular intensive physical exercise for \>30 minute daily

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Massachusetts General Hospital

Boston, Massachusetts, 02114, United States

Location

Related Publications (5)

  • Mace RA, Doorley JD, Popok PJ, Vranceanu AM. Live Video Adaptations to a Mind-Body Activity Program for Chronic Pain and Cognitive Decline: Protocol for the Virtual Active Brains Study. JMIR Res Protoc. 2021 Jan 4;10(1):e25351. doi: 10.2196/25351.

    PMID: 33208301BACKGROUND
  • Mace RA, Gates MV, Popok PJ, Kulich R, Quiroz YT, Vranceanu AM. Feasibility Trial of a Mind-Body Activity Pain Management Program for Older Adults With Cognitive Decline. Gerontologist. 2021 Nov 15;61(8):1326-1337. doi: 10.1093/geront/gnaa179.

    PMID: 33159516BACKGROUND
  • Mace RA, Gates MV, Bullard B, Lester EG, Silverman IH, Quiroz YT, Vranceanu AM. Development of a Novel Mind-Body Activity and Pain Management Program for Older Adults With Cognitive Decline. Gerontologist. 2021 Apr 3;61(3):449-459. doi: 10.1093/geront/gnaa084.

    PMID: 32601670BACKGROUND
  • Doorley JD, Mace RA, Popok PJ, Grunberg VA, Ragnhildstveit A, Vranceanu AM. Feasibility Randomized Controlled Trial of a Mind-Body Activity Program for Older Adults With Chronic Pain and Cognitive Decline: The Virtual "Active Brains" Study. Gerontologist. 2022 Aug 12;62(7):1082-1094. doi: 10.1093/geront/gnab135.

    PMID: 34487167BACKGROUND
  • Vranceanu AM, Choukas NR, Rochon EA, Duarte B, Pietrzykowski MO, McDermott K, Hooker JE, Kulich R, Quiroz YT, Parker RA, Macklin EA, Ritchie C; Active Brains Project; Mace RA. Addressing the Chronic Pain-Early Cognitive Decline Comorbidity Among Older Adults: Protocol for the Active Brains Remote Efficacy Trial. JMIR Res Protoc. 2023 Sep 28;12:e47319. doi: 10.2196/47319.

MeSH Terms

Conditions

Chronic PainCognitive DysfunctionMotor Activity

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsCognition DisordersNeurocognitive DisordersMental DisordersBehavior

Study Officials

  • Ana-Maria Vranceanu, PhD

    Massachusetts General Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor/Director

Study Record Dates

First Submitted

April 15, 2022

First Posted

May 13, 2022

Study Start

June 20, 2022

Primary Completion

December 31, 2025

Study Completion (Estimated)

December 31, 2026

Last Updated

February 23, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Locations